rp 73401 has been researched along with trequinsin in 2 studies
| Studies (rp 73401) | Trials (rp 73401) | Recent Studies (post-2010) (rp 73401) | Studies (trequinsin) | Trials (trequinsin) | Recent Studies (post-2010) (trequinsin) |
|---|---|---|---|---|---|
| 92 | 0 | 23 | 54 | 0 | 14 |
| Protein | Taxonomy | rp 73401 (IC50) | trequinsin (IC50) |
|---|---|---|---|
| cGMP-dependent 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 1.9502 | |
| Multidrug resistance-associated protein 4 | Homo sapiens (human) | 10 | |
| High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | Homo sapiens (human) | 1.9502 | |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Homo sapiens (human) | 1.9502 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | Homo sapiens (human) | 0.4 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | Homo sapiens (human) | 0.4 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | Homo sapiens (human) | 0.4 | |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | Homo sapiens (human) | 1.4334 | |
| cGMP-inhibited 3',5'-cyclic phosphodiesterase A | Homo sapiens (human) | 1.9502 | |
| cGMP-specific 3',5'-cyclic phosphodiesterase | Bos taurus (cattle) | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashton, TD; Bland, ND; Campbell, RK; Cotter, K; Fang, AP; Gangurde, R; Garceau, N; Gechijian, L; Gustafson, AE; McAllister, G; Ochiana, SO; Ondrechen, MJ; Ortenberg, R; Pollastri, MP; Tallman, C; Wang, C; Wang, Z | 1 |
| Alves, AC; Barreto, EO; Cordeiro, RS; Jose, PJ; Lagente, V; Martins, MA; Pires, AL; Serra, MF; Silva, JP; Silva, PM; Teixeira, MM | 1 |
2 other study(ies) available for rp 73401 and trequinsin
| Article | Year |
|---|---|
Pharmacological validation of Trypanosoma brucei phosphodiesterases B1 and B2 as druggable targets for African sleeping sickness.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Benzamides; Catalytic Domain; Humans; Models, Molecular; Molecular Structure; Pyridines; Recombinant Proteins; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African | 2011 |
Modulation of eotaxin formation and eosinophil migration by selective inhibitors of phosphodiesterase type 4 isoenzyme.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Albuterol; Allergens; Animals; Benzamides; Bronchoalveolar Lavage Fluid; Capillary Permeability; Cell Adhesion; Cell Degranulation; Cell Movement; Chemokine CCL11; Chemokines, CC; Chemotaxis, Leukocyte; Cyclic Nucleotide Phosphodiesterases, Type 4; Cytokines; Dose-Response Relationship, Drug; Eosinophils; Female; Guinea Pigs; Immune Sera; Isoenzymes; Isoquinolines; Male; Mast Cells; Ovalbumin; Phosphodiesterase Inhibitors; Pleurisy; Pyridines; Rats; Rats, Wistar; Rolipram; Tetrahydroisoquinolines | 2001 |